AilsynBio and Dong-E-E-Jiao Sign Project Cooperation Agreement Empowering Traditional Medicine with AI
AilsynBio, an AI-driven drug discovery company, signed a project cooperation agreement with Dong-E-E-Jiao on April 10, 2026.
The signing ceremony took place at the Hong Kong Science Park.
The agreement aims to empower traditional medicine with AI, opening a new chapter in the health industry.
Published 2 days ago via Media OutReach Newswire.